Tivic Health Systems Research and Development Expenses 2020-2024 | TIVC

Tivic Health Systems research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Tivic Health Systems Annual Research and Development Expenses
(Millions of US $)
2024 $1
2023 $2
2022 $2
2021 $1
2020 $1
2019 $1
Tivic Health Systems Quarterly Research and Development Expenses
(Millions of US $)
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31 $0
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.003B $0.001B
Tivic Health Systems Inc. is a commercial-phase healthtech company advancing bioelectronic medicine to deliver non-invasive solutions which treat disease, increase wellness and improve lives. Its first product includes ClearUP(R). Tivic Health Systems Inc. is based in MENLO PARK, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.476B 53.14
Tempus AI (TEM) United States $9.826B 0.00
Hims & Hers Health (HIMS) United States $9.069B 145.79
Inspire Medical Systems (INSP) United States $4.756B 92.38
IRhythm Technologies (IRTC) United States $4.186B 0.00
Privia Health (PRVA) United States $2.829B 212.00
Enovis (ENOV) United States $2.016B 12.47
Schrodinger (SDGR) United States $1.847B 0.00
Clover Health Investments (CLOV) United States $1.706B 0.00
Phreesia (PHR) United States $1.512B 0.00
Omnicell (OMCL) United States $1.460B 31.48
Azenta (AZTA) United States $1.232B 57.36
10x Genomics (TXG) United States $1.031B 0.00
Fulgent Genetics (FLGT) United States $0.634B 0.00
Butterfly Network (BFLY) United States $0.566B 0.00
Talkspace (TALK) United States $0.537B 319.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.456B 0.00
TruBridge (TBRG) United States $0.392B 0.00
Claritev (CTEV) United States $0.362B 0.00
Health Catalyst (HCAT) United States $0.294B 0.00
Nyxoah SA (NYXH) Belgium $0.208B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.202B 0.00
Pulmonx (LUNG) United States $0.152B 0.00
American Well (AMWL) United States $0.116B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
Retrieve Medical Holdings (RMHI) United States $0.085B 0.00
MDxHealth SA (MDXH) Belgium $0.081B 0.00
CareCloud (CCLD) United States $0.080B 3.43
111 (YI) China $0.072B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Precipio (PRPO) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00